Petros Pharmaceuticals Ownership 2024 | Who Owns Petros Pharmaceuticals Now?
Institutional Ownership
3.35%
Insider Ownership
8.44%
Retail Ownership
88.21%
Institutional Holders
13.00
Petros Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BLACKROCK INC. | 0.80% | - | 16,510 | 3 | 0.02% | 23,031,000 | Mar 31, 2023 |
VANGUARD GROUP INC | 0.53% | - | 10,889 | -8,902 | -44.98% | 15,190,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.11% | 0.00% | 2,310 | 1,807 | 359.24% | 3,000 | Mar 31, 2023 |
EMFO, LLC | 0.05% | 0.00% | 1,000 | - | - | 1,395,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 17 | - | - | 24,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 14 | 14 | 100.00% | 20,000 | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 14 | 12 | 600.00% | 19,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 10 | - | - | 14,000 | Mar 31, 2023 |
FIRST MANHATTAN CO. LLC. | 0.00% | - | 10 | - | - | 13,000 | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -1,098 | -100.00% | - | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -200 | -100.00% | - | Mar 31, 2023 |
Petros Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 0.80% of the company's total share outstanding, currently valued at $23.03M. The top 10 institutional shareholders own together 1.49% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
EMFO, LLC | 0.05% | 0.00% | 1,000 | - | - | 1,395,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.11% | 0.00% | 2,310 | 1,807 | 359.24% | 3,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.80% | - | 16,510 | 3 | 0.02% | 23,031,000 | Mar 31, 2023 |
VANGUARD GROUP INC | 0.53% | - | 10,889 | -8,902 | -44.98% | 15,190,000 | Mar 31, 2023 |
FIRST MANHATTAN CO. LLC. | 0.00% | - | 10 | - | - | 13,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 14 | 14 | 100.00% | 20,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 10 | - | - | 14,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 17 | - | - | 24,000 | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 14 | 12 | 600.00% | 19,000 | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -1,098 | -100.00% | - | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -200 | -100.00% | - | Mar 31, 2023 |
The largest Petros Pharmaceuticals shareholder by % of total assets is EMFO, LLC. The company owns 1.00K shares of Petros Pharmaceuticals (PTPI), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TOWER RESEARCH CAPITAL LLC (TRC) | 0.11% | 0.00% | 2,310 | 1,807 | 359.24% | 3,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 14 | 14 | 100.00% | 20,000 | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 14 | 12 | 600.00% | 19,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.80% | - | 16,510 | 3 | 0.02% | 23,031,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 17 | - | - | 24,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 10 | - | - | 14,000 | Mar 31, 2023 |
FIRST MANHATTAN CO. LLC. | 0.00% | - | 10 | - | - | 13,000 | Mar 31, 2023 |
EMFO, LLC | 0.05% | 0.00% | 1,000 | - | - | 1,395,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -200 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -1,098 | -100.00% | - | Mar 31, 2023 |
VANGUARD GROUP INC | 0.53% | - | 10,889 | -8,902 | -44.98% | 15,190,000 | Mar 31, 2023 |
As of Mar 31 2023, Petros Pharmaceuticals's largest institutional buyer is TOWER RESEARCH CAPITAL LLC (TRC). The company purchased 1.81K stocks of PTPI, valued at $3.00K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VANGUARD GROUP INC | 0.53% | - | 10,889 | -8,902 | -44.98% | 15,190,000 | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -1,098 | -100.00% | - | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -200 | -100.00% | - | Mar 31, 2023 |
EMFO, LLC | 0.05% | 0.00% | 1,000 | - | - | 1,395,000 | Mar 31, 2023 |
FIRST MANHATTAN CO. LLC. | 0.00% | - | 10 | - | - | 13,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 10 | - | - | 14,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 17 | - | - | 24,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.80% | - | 16,510 | 3 | 0.02% | 23,031,000 | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 14 | 12 | 600.00% | 19,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 14 | 14 | 100.00% | 20,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.11% | 0.00% | 2,310 | 1,807 | 359.24% | 3,000 | Mar 31, 2023 |
As of Mar 31 2023, Petros Pharmaceuticals's biggest institutional seller is VANGUARD GROUP INC. The company sold -8.90K shares of PTPI, valued at $15.19M.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 14 | 14 | 100.00% | 20,000 | Mar 31, 2023 |
Petros Pharmaceuticals's largest new institutional shareholder by number of shares is ADVISOR GROUP HOLDINGS, INC., purchased 14.00 shares, valued at $20.00K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | - | - | - | -1,098 | -100.00% | - | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -200 | -100.00% | - | Mar 31, 2023 |
Petros Pharmaceuticals's largest sold out institutional shareholder by shares sold is UBS GROUP AG, sold -1.10K shares, valued at -, as of undefined.
Petros Pharmaceuticals Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
VANGUARD INDEX FUNDS | 0.00% | 255,914 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 69,023 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 31,811 | -31,811 | -50.00% | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 9,957 | - | - | Feb 29, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 972 | - | - | Jan 31, 2024 |
iSHARES TRUST | 0.00% | 25,321 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 1,299 | - | - | Mar 31, 2024 |
Petros Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 255.91K shares, compromising 0.00% of its total assets.
Petros Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Sep, 22 | 13 | -7.14% |
30 Jun, 22 | 14 | -26.32% |
31 Mar, 22 | 19 | -9.52% |
31 Dec, 21 | 21 | 40.00% |
30 Sep, 21 | 15 | -16.67% |
30 Jun, 21 | 18 | 5.88% |
31 Mar, 21 | 17 | -15.00% |
31 Dec, 20 | 20 | - |
As of 30 Sep 22, 13 institutions are holding Petros Pharmaceuticals's shares, representing a decrease of -7.14% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Sep, 22 | 693,567 | 3.04% |
30 Jun, 22 | 673,120 | -19.27% |
31 Mar, 22 | 833,814 | -22.46% |
31 Dec, 21 | 1,075,312 | 32.37% |
30 Sep, 21 | 812,328 | -15.67% |
30 Jun, 21 | 963,310 | -15.24% |
31 Mar, 21 | 1,136,521 | 28.30% |
31 Dec, 20 | 885,862 | - |
Petros Pharmaceuticals (PTPI) has 693.57K shares outstanding as of 30 Sep 22, up 3.04% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Sep, 22 | 3.35% | 31.65% |
30 Jun, 22 | 3.25% | 20.03% |
31 Mar, 22 | 4.03% | 4.13% |
31 Dec, 21 | 9.87% | 17.74% |
30 Sep, 21 | 7.46% | 9.53% |
30 Jun, 21 | 8.85% | 8.12% |
31 Mar, 21 | 10.44% | 15.77% |
31 Dec, 20 | 8.13% | - |
As of 30 Sep 22, Petros Pharmaceuticals is held by 3.35% institutional shareholders, representing a 31.65% growth compared to 30 Jun 22.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Sep, 22 | 4 | -33.33% |
30 Jun, 22 | 6 | -40.00% |
31 Mar, 22 | 10 | -33.33% |
31 Dec, 21 | 15 | 400.00% |
30 Sep, 21 | 3 | -70.00% |
30 Jun, 21 | 10 | 25.00% |
31 Mar, 21 | 8 | -60.00% |
31 Dec, 20 | 20 | - |
4 institutional shareholders have increased their position in PTPI stock as of 30 Sep 22 compared to 6 in the previous quarter (a -33.33% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Sep, 22 | 1 | -50.00% |
30 Jun, 22 | 2 | - |
31 Mar, 22 | 2 | -33.33% |
31 Dec, 21 | 3 | -40.00% |
30 Sep, 21 | 5 | - |
30 Jun, 21 | 5 | 150.00% |
31 Mar, 21 | 2 | - |
31 Dec, 20 | - | - |
1 institutional shareholders have reduced their position in PTPI stock as of 30 Sep 22 compared to 2 in the previous quarter (a -50.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Sep, 22 | 13 | -7.14% | 693,567 | 3.04% | 3.35% | 31.65% | 4 | -33.33% | 1 | -50.00% |
30 Jun, 22 | 14 | -26.32% | 673,120 | -19.27% | 3.25% | 20.03% | 6 | -40.00% | 2 | - |
31 Mar, 22 | 19 | -9.52% | 833,814 | -22.46% | 4.03% | 4.13% | 10 | -33.33% | 2 | -33.33% |
31 Dec, 21 | 21 | 40.00% | 1,075,312 | 32.37% | 9.87% | 17.74% | 15 | 400.00% | 3 | -40.00% |
30 Sep, 21 | 15 | -16.67% | 812,328 | -15.67% | 7.46% | 9.53% | 3 | -70.00% | 5 | - |
30 Jun, 21 | 18 | 5.88% | 963,310 | -15.24% | 8.85% | 8.12% | 10 | 25.00% | 5 | 150.00% |
31 Mar, 21 | 17 | -15.00% | 1,136,521 | 28.30% | 10.44% | 15.77% | 8 | -60.00% | 2 | - |
31 Dec, 20 | 20 | - | 885,862 | - | 8.13% | - | 20 | - | - | - |
Petros Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Petros Pharmaceuticals's stock was made by Bradley Greg on Apr 28 2023, selling 6,050 shares at - per share (valued at -).
Petros Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2023 | 8 | 4 | 200.00% |
Q1 2023 | 4 | 4 | 100.00% |
Q2 2022 | 4 | - | - |
Q4 2021 | 10 | - | - |
Q2 2021 | 7 | - | - |
Q1 2021 | 1 | - | - |
Q4 2020 | 14 | 9 | 155.56% |
Q1 2020 | - | 1 | - |
8 total buy trades, and 4 total sell trades (buy/sell ratio of 2.00%) were made by Petros Pharmaceuticals's insiders, as of Q2 2023.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q2 2022 | - | - | - |
Q4 2021 | 6 | - | - |
Q2 2021 | - | - | - |
Q1 2021 | - | - | - |
Q4 2020 | - | - | - |
Q1 2020 | - | - | - |
As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Petros Pharmaceuticals's stocks.
Petros Pharmaceuticals Peer Ownership
Ticker | Company |
---|---|
SNOA | Sonoma Pharmaceuticals, Inc. |
AKAN | Akanda Corp. |
EVOK | Evoke Pharma, Inc. |
TKNO | Alpha Teknova, Inc. |
SBFM | Sunshine Biopharma, Inc. |
LFCR | Lifecore Biomedical, Inc. |
GHSI | Guardion Health Sciences, Inc. |
ALIM | Alimera Sciences, Inc. |
SHPH | Shuttle Pharmaceuticals Holdings, Inc. |
CPIX | Cumberland Pharmaceuticals Inc. |
ADMP | Adamis Pharmaceuticals Corporation |
LSDI | Lucy Scientific Discovery Inc. |
PRFX | PainReform Ltd. |
AGRX | Agile Therapeutics, Inc. |
SXTC | China SXT Pharmaceuticals, Inc. |
PTPI Ownership FAQ
Who Owns Petros Pharmaceuticals?
Petros Pharmaceuticals is owned by institutional shareholders (3.35%), insiders (8.44%), and public (88.21%). The largest institutional shareholder of Petros Pharmaceuticals is BLACKROCK INC. (0.80% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).
Who are the major institutional shareholders of Petros Pharmaceuticals?
Petros Pharmaceuticals's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, TOWER RESEARCH CAPITAL LLC (TRC), EMFO, LLC, and MORGAN STANLEY. The top five shareholders own together 1.48% of the company's share outstanding.
How many Petros Pharmaceuticals shareholders are there?
As of Sep 2022, there are 13 institutional shareholders of Petros Pharmaceuticals.
What percentage of Petros Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC owns 16.51K shares of Petros Pharmaceuticals, representing 0.80% of the company's total shares outstanding, valued at $23.03M (as of Mar 2023).
What percentage of Petros Pharmaceuticals is owned by VANGUARD GROUP INC?
As of Mar 2023, VANGUARD GROUP INC holds 10.89K shares of Petros Pharmaceuticals (PTPI), compromising 0.53% of the company, valued at $15.19M.
What percentage of Petros Pharmaceuticals is owned by TOWER RESEARCH CAPITAL LLC (TRC)?
TOWER RESEARCH CAPITAL LLC (TRC) is the third largest holder of Petros Pharmaceuticals. The company owns 2.31K of the company's shares outstanding (worth $3K).